BioPharma Selank 10mg

Often stacked with: Semax 5mg

Discover Selank 10mg, a synthetic heptapeptide analog of the endogenous immunomodulatory peptide tuftsin. With the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, Selank was developed at the Russian Academy of Sciences and has been used clinically in Russia as an anxiolytic and nootropic agent. The addition of a Pro-Gly-Pro stabilizing sequence improves metabolic stability compared with native tuftsin.

The 10mg vial strength is a common research format suitable for laboratory protocols investigating anxiety reduction, stress resilience, cognitive performance under load, and related neuroimmune pathways.

Key Research Areas of Interest for Selank 10mg

•  Anxiolytic effects studied in generalized anxiety and related conditions, with some Russian clinical data showing activity comparable to certain benzodiazepines without classic sedative or dependence profiles.

•  Mild nootropic and antiasthenic support, including potential benefits for attention, mental clarity, and recovery from fatigue.

•  Modulation of GABAergic signaling and elevation of endogenous enkephalins via enkephalinase inhibition.

•  Influence on monoamine systems (serotonin, dopamine, noradrenaline) and upregulation of BDNF expression.

•  Immunomodulatory research interest stemming from its tuftsin-derived structure.

•  Investigation of functional brain connectivity and stress-related cognitive performance.

How Selank Works

Selank acts through multiple complementary pathways rather than a single receptor:

•  Modulation of the GABA system (enhancing inhibitory tone in a manner distinct from direct benzodiazepine-site binding).

•  Inhibition of enkephalin-degrading enzymes, raising levels of endogenous opioid peptides involved in stress and mood regulation.

•  Effects on monoamine neurotransmission and neurotrophic factors such as BDNF.

•  Broader neuroimmune signaling linked to its origin as a tuftsin analog.

These mechanisms support research into calm focus, reduced anxiety reactivity, and cognitive resilience without the typical side-effect profile of classical anxiolytics.

Administration & Protocol Considerations

In Russian pharmaceutical practice, Selank is most commonly administered intranasally (typical ranges 150–600 mcg per dose, 2–3 times daily for courses of 10–14 days). The 10mg research vial allows flexible reconstitution for laboratory or clinician-supervised protocols, including subcutaneous or nasal delivery routes used in research settings. Cycling approaches (e.g., 10–14 days on followed by a break) are frequently discussed in the literature and community research contexts.

Selank is not FDA-approved in the United States for any indication and remains a research compound in most Western jurisdictions.

Common Side Effects & Safety Profile

Available clinical and research data from Russian sources describe a generally favorable tolerability profile. The most commonly noted effects with intranasal use are mild nasal irritation or dryness. Occasional transient headache or mild stimulatory/sedative sensations have been reported. Classic benzodiazepine-associated effects such as significant sedation, cognitive impairment, muscle relaxation, tolerance, or withdrawal are not characteristic in the published comparisons. Individual responses vary; monitoring is advised in any supervised setting.

Critical Disclaimer: Selank 10mg is intended for laboratory research or use under qualified medical supervision only. It is not an FDA-approved drug in the United States and is not intended to diagnose, treat, cure, or prevent any disease. Not for self-administration without proper training and oversight. Source only from reputable suppliers providing third-party purity testing and Certificates of Analysis. Consult a licensed healthcare professional before any use. Results are not guaranteed and depend on individual factors, purity, and protocol.

Advance your anxiolytic and cognitive research with high-purity Selank 10mg. Verify testing documentation and prioritize quality-sourced material for reproducible results.